Skip to main content

UBS Group AG

Position in PHVS — Pharvaris N.V.

CIK 1610520 ZURICH, V8

Position in PHVS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$2,032,333
-$1,789,785 QoQ
Shares Held
71,941
-47.8% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PHVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. PHVS ranks #210 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PHVS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,032,333 71,941
2025-12-31 $3,822,118 137,734
2025-09-30 $3,262,261 130,752
2025-06-30 $65,876 3,743
2025-03-31 $116,949 7,449
2024-12-31 $20,032 1,045
2024-09-30 $29,464 1,591
2024-06-30 $3,139 167
2023-09-30 $1,043 50
2023-06-30 $19,682 1,300
2023-03-31 $3,399 422
2022-12-31 $31,500 2,800
2022-06-30 $17,657 799
2022-03-31 $13,202 728
2021-12-31 $6,086 423
2021-09-30 $11,595 654
2021-03-31 $895 32